Conquering Diseases

Study Of An Investigational Drug Given Alone Or In Combination With A Standard Treatment For Myelofibrosis

Description

Seeking men and women with myelofibrosis bone marrow cancer for a study of an investigational drug given alone or in combination with a standard treatment.

Overview

Based on their current treatment and illness, participants in this study will get the standard drug in combination with either a high or low dose of the investigational drug, or a high dose of the investigational drug alone.

What we're hoping for

We are studying whether an investigational drug given alone or in combination with a standard drug for myelofibrosis bone marrow cancer is safe and effective in preventing the disease from progressing.

Additional Information

ClinicalTrials.gov Identifier: NCT03222609

 Principal Investigator

Jonathan M. Gerber, MD

University of Massachusetts Medical School

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989